Faricimab

Indication

wet age-related macular degeneration - NICE TA800

Red

Brand:

Nice TA:

800

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:

Eye

1.1 Faricimab is recommended as an option for treating wet age-related macular degeneration in adults, only if:

the eye has a best-corrected visual acuity between 6/12 and 6/96
there is no permanent structural damage to the central fovea
the lesion size is 12 disc areas or less in greatest linear dimension
there are signs of recent disease progression (for example, blood vessel growth as shown by fluorescein angiography, or recent visual acuity changes)
the company provides faricimab according to the commercial arrangement.

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

BwD	BP	CSR	EL	FW	GP	MB	WL
Red	Red	Red	Red	Red	Red	Red	Red

What do the colours mean?

Last Updated: 15 - Jul - 2022